WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable

From the article:

The problem of drug prices eating up national health budgets has been coming up at the annual World Health Assembly. Last week, a panel of experts discussed the merits of lowering those prices by delinking research and development costs from pricing.

….

It would be best if the government does the studies so they will be taken most seriously. Their prediction is that a comparison will show delinkage is a better approach.

Several vectors moving here and they share the principle that a private-sector monopoly (or equivalent) is the problem, not the solution and that if the society made up of the individuals using the medications is to survive as a society (and not simply as a thick clot of mall rats) then rational approaches are required, so as to determine the right paths to take (and also to un-take).

WHA 68: Experts Discuss Delinking R&D Costs From Pricing To Make Medicines Affordable.